A more recent study found methylation differences at only one of the CpG sites in the BRCA1 promoter in the blood of breast cancer women and pre-diagnostic breast cancer cases and again here detected methylation level difference were less than 2%11. The gene discussed is BRCA1; the disease is breast carcinoma.